Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer

Description

This is an observational study involving the collection of patient-generated health data using an Apple Watch, a home pulse oximeter, and a smartphone during a course of proton beam radiotherapy for lung cancer. The study period over which this information is collected will range from the day of study enrollment until two weeks after radiotherapy completion. Subjects will complete a short satisfaction survey at the end of the study period. Other information that is collected as part of routine care for this patient population will be extracted from subjects' medical records during the study period and afterwards.

Conditions

Thoracic Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

This is an observational study involving the collection of patient-generated health data using an Apple Watch, a home pulse oximeter, and a smartphone during a course of proton beam radiotherapy for lung cancer. The study period over which this information is collected will range from the day of study enrollment until two weeks after radiotherapy completion. Subjects will complete a short satisfaction survey at the end of the study period. Other information that is collected as part of routine care for this patient population will be extracted from subjects' medical records during the study period and afterwards.

Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer: A Pilot Study

Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer

Condition
Thoracic Cancer
Intervention / Treatment

-

Contacts and Locations

New York

New York Proton Center, New York, New York, United States, 10035

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Plan for fractionated (≥15 treatments) proton beam thoracic radiotherapy with curative intent for lung cancer
  • * Non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) histology is permitted.
  • * Concurrent chemotherapy is permitted but not required..
  • * Previous thoracic radiotherapy is allowed.
  • * Ability to complete study surveys in English or Spanish
  • * Age \>/= 18
  • * Concurrent enrollment on other trials is permitted
  • * Patients who already use wearable devices and/or smartphones that monitor physical activity are eligible for this trial, provided they agree to utilize the devices provided by the study team during the study period
  • * All patients must sign study-specific informed consent prior to study entry
  • * Ongoing treatment for another cancer that is expected to affect the toxicity profile of thoracic radiotherapy
  • * Pregnancy or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception; this exclusion is necessary because the treatment involved in this study may be significantly teratogenic

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

The New York Proton Center,

Nitin Ohri, MD, PRINCIPAL_INVESTIGATOR, Montefiore Medical Center

Study Record Dates

2031-03-21